Introduction
The population dynamics of the UK are changing. The last 25 years has seen an increase in the number of people above the age of 65 by 1.7 million [1] . If we look at projected forecasts to 2034 then 23% of our population will be 65 or above [1] . Perhaps what is even more surprising is that the fastest population increase has been in the number of those aged 85 and over. In 1984, there were around 660,000 people in the UK aged 85 and over, by 2009 this had doubled to 1.4 million. Forecast projections put the number of this age group at 3.5 million or 5% of the UK population by 2034 [2] . The trend is also being replicated in Europe and United States [3] . In fact, the growth of the octogenarian population is estimated to triple by 2050 across Europe [1] .
Heart disease remains the leading cause of death for both men and women of all ages [4] . This population shift will obviously have implications on health budgets. For example, patients aged 75 and older represent one third of those hospitalized with acute ischemic events and account for more than half of all cardiac deaths [5] . Patients over 75 years of age have twice the mortality rates than patients below 75 years of age [6] . Age has now been recognized as one of the most important risk predictors in patients admitted with a non-ST elevation myocardial infarction (NSTEMI) [7] . However due to lack of data on the management of acute coronary syndromes (ACS) in this age group some ambiguity remains in evidence based treatment of octogenarians. The current guidelines from the European Society of Cardiology strongly advice to take into consideration estimated life expectancy, co-morbidities and quality of life prior to any decisions in the management of our older NSTEMI patients [6] .
We conducted an audit to investigate the management of patients aged 80 and above, who were admitted to our institution with a diagnosis of either ST elevation myocardial infarction (STEMI) or a NSTEMI or NSTE-ACS and compared our practice to the recommended guidelines for management of these conditions.
Methods
We conducted a retrospective analysis of the management of patients aged 80 and above that were admitted with troponin positive chest pain during 2010. These patients were either treated as STEMI or as NSTEMI. The list of troponin positive patients admitted between the 1 st of January 2010 and the 31 st of December 2010 was obtained from our medical records department. This list was further cross checked with the MINAP database and the clinical governance department. We then separated patient's that were 80 or above into our study group. Patient information thereafter was primarily obtained from our computer data base system that includes blood results, ECHOs, diagnostic angiograms, discharge and clinic letters. If the information was inadequate we obtained patient files or contacted the relevant general practitioner. This audit has been registered with our audit department.
Results
There were a total of 510 patients who were admitted with a diagnosis of a myocardial infarction (MI) (either STEMI or NSTEMI) to Good Hope Hospital during the period from 1 st January 2010 to 31 st December 2010. Of these, 177 were above the age of 80 representing 35% of the patients with an ACS. The male to female ratio was almost equally split at 49.7% and 50.3%, respectively. The mean and median ages were 86.2 and 86 years respectively (Fig. 1) . Table 1 summarizes the past medical history of these patients. Interestingly, more than half of the patients had no previous history of diabetes mellitus, MI, percutaneous coronary intervention (PCI) or coronary artery bypass grafts (CABG). However 78% had hypertension and 48% had previous strokes. There was also a higher prevalence of other co-morbidities (Table 1) , including dementia (21%), malignancy (13%), previous gastro intestinal bleed (5%) and chronic renal impairment (12%). Figure 2 demonstrates the range of comorbidities that were present, with only 10 (6%) patients having no comorbidities, whilst 4 (2%) patients had more than 7. We also found that 106 (61%) and 8 (4%) of our patients were ex-smokers or continued to smoke respectively.
The majority of patients presented with the only symptom being chest pain (80%). However a further 15% had presented with chest pain along with another symptom ( Table 2 ). The remaining 5% of patients denied any chest pain and presented with other complaints, the reasons for performing troponin levels were not made clear. It was considered to be an incidental finding as the patients had presented with totally non cardiac symptoms and the troponin was sent as part of routine testing. These patients were therefore excluded from the analysis. 22% (39 patients) of the patients in our study were found to be in atrial fibrillation (AF) on admission. Only 2 out of the 39 patients had complained www.cardiologyjournal.org of palpitations as the presenting complaint. Therefore AF was an incidental finding in 37 patients.
Of the total 177 patients, 86 were transferred under the care of the cardiology team with the remaining 91 staying under the care of the general medical team. Of the 91 patients that remained under the care of the general medical teams 21 (23%) were discussed with the cardiologist. The most common reason for the cardiology team not accepting a patient or for the medical team not referring patients to the cardiologist was the presence of significant comorbidities such as dementia or advanced malignancy (89%). Two patients had requested medical management and another 5 patients had sepsis.
We found that 59 of the 86 (69%) patients that were admitted or transferred under cardiology care had diagnostic angiography. The reasons for not performing angiography on the remaining 27 patients are listed in Figure 3 . The commonest reason for 32% or 10 patients was for a trial of medical therapy in the first instance with a view to take a more invasive approach if that failed. In 4 (15%) patients of patients no clear explanation was documented as to why diagnostic coronary angiography was not performed (Fig. 3) .
Of the 59 patients that underwent diagnostic angiography 34 (58%) patients were for medical management. 32 of these patients had no flow limiting disease, described as less than 75% stenosis, therefore not requiring intervention. The remaining 2 patients were deemed to be too frail for any intervention as they had extensive coronary artery disease. It is therefore not clear why they underwent any invasive test in the first place.
Out of the 25 patients with significant disease demonstrated on diagnostic coronary angiography, 19 had PCI, 4 had CABG but 2 patients opted for medical management only. The frequency of the coronary vessels stented were 5 (16%), 9 (30%), 8 (27%) and 8 (27%) for left main stem, left anterior descending, circumflex (including obtuse marginal) and right coronary, respectively. The frequency of single, double, triple and quadruple stents implanted were 4 (23%), 7 (37%), 5 (26%) and 3 (18%) respectively. Therefore in summary, of the 19 patients that underwent PCI, 15 (75%) required more than 1 stent and 15 (75%) required more than 1 coronary artery to be stented with nearly half of the patients requiring stenting of either the left main or the left anterior descending artery.
We compared patient length of in-hospital stay depending on whether they were under the general medical or cardiology team (Fig. 4) . We found that the length of stay under the cardiologists was less. The mean/median lengths of stay under cardiology department and general medical departments were 5.9/5 and 10.4/10 days, respectively. 61% of patients under the cardiologists were discharged within 5 days whereas only 32% of the patients under the medical team were discharge within this time frame.
During the following year, we found that 17 (10%) patients of study population died. Six patients had out of hospital cardiac arrests and were not revived. The remaining 11 patients died whilst as inpatients. Nine of these patients died within 24 h from cardiogenic shock or aspirational pneumonia, 7 of these 9 patients were discussed with the cardiology team and were for medical/palliative treatment only. Out of the remaining 2 patients, both had prolonged admissions, ultimately dying from bronchopneumonia. No deaths were reported whilst under the care of the cardiology team Eight patients died before being seen in the follow up clinic, 2 from cardiac causes and 6 non cardiac causes. Of the 19 patients that had PCI 18 were alive at 12 months, 1 patient had died from a non-cardiac cause, 2 patients had recurrence of their symptoms of which 1 patient had a further NSTEMI. However both had repeat diagnostic angiogram with patent stents and without flow limiting disease.
All patients that had CABG were followed up and were alive at 12 months.
Discussion
Recent Myocardial infarction National Audit Project (MINAP) data noted the average age of patients with NSTEMI was 70 years of age and for first presentation STEMI was 65 years of age, with 52% of all myocardial infarcts occurring in patients aged 70 or above [8] . Taking into account European registries 27-34% of NSTEMI patients were 75 years or over [9, 10] , however less than 20% of patients aged 75 years or more were included in clinical trials [11] . This has led to some ambiguity in the treatment of octogenarians with ACS and therefore age dependent inequalities in the management of these patients [12] . Despite this, significant reduction in hospital mortality of ACS patients in England and Wales has been seen across all age groups [12] .
The management of elderly patients with an ACS is challenging. The risk of complications of an invasive strategy is high in this population group [13, 14] , however these high risk patients are often those with the most to gain [15] [16] [17] [18] [19] . With the ageing population the decision whether to medically manage or subject patients to an interventional procedure are a common clinical dilemma.
In our study we found that around one-third of patients who were admitted with an ACS were above the age of 80. This is in keeping with other studies [5] . Around half of the patients who were admitted, however remained under the admitting medical team with 70 of the total 177 (39%) not even being discussed with the cardiology team. This is potentially a contentious point -whether the decision to investigate these patients further should be taken in conjunction with the cardiologists or whether the admitting medical team could make the decision. Currently there are no national or international guideline recommendations on who makes the decision. The ESC guidelines only recommend that any decision should be based on individual elderly patients, taking into account, "ischemic and bleeding risk, estimated life expectancy, co-morbidities, quality of life, patient wishes, and the estimated risks and benefits of revascularization" [6] .
Only a third of our study group had an angiogram. It is not clear from the records whether the decision not to have any invasive testing was taken in conjunction with the patient or whether it was a medical decision. It was clearly documented only in 6 patients that the patient did not wish to have any invasive investigation done. Similarly in about 10 patients who were under the cardiologists, the plan was for medical therapy in the first instance, with a view to invasive testing if the patient failed medical therapy. This is debatable, as clinical evidence suggests that in the setting of an ACS, an early invasive strategy is far superior to a conservative strategy [12, 13] . Although not documented in the medical notes, it is possible that these patients either had significant co-morbidities or were physically frail or had other reasons for the treating clinician to make that decision. However this was not clear from the medical notes.
There was an overall mortality rate of 17 (10%) patients in our octo-nonagenarians group. Six were out patient cardiac arrests that could not be resuscitated, the remaining 11 patients died during their stay in hospital. The majority (9 of the 11) died within 24 h from cardiogenic shock. The remaining 2 died after a prolonged in patient stay in hospital with bronchopneumonia. These 2 patients had a number of comorbidities including dementia.
Patients with the greater number of comorbidities remained under the care of the medical teams and as mentioned above had no cardiac intervention. These are also the patients not surprisingly who had a longer length of stay. Within this context great care needs to be exercised and to ensure that all suitable patients are at least considered for intervention if required. This has been highlighted in some studies that found patients admitted with NSTEMI had lower mortality if under cardiac care than general medical care [20, 21] . These studies included all ages and not only octogenarians.
Patient comorbidities are a very important and integral part of the decision making process in the elderly. 94% of our patients had at least a 1 significant comorbidity, with 21% and 5% having a history of dementia and gastrointestinal bleeding respectively. Informed consent and the reasons for performing an invasive procedure that has an associated complication risk must be clearly explained with simple grammar and highlighting important points [22, 23] . We found that 22% of patients that did not have diagnostic angiograms didn't have it done at their own request. If a decision not to pursue an invasive procedure is made, then clear documentation of the reason must always be made.
If however patients agree to undergo intervention then stressing the importance of post-procedural compliance of any treatment is associated with improved patient outcomes [24, 25] .
In our study 39 (22%) of the patients were found to be in AF on admission. However, only 2 out of the 39 patients had complained of palpitations as the presenting complaint. Therefore AF was an incidental finding in 37 patients as mentioned within the results. The prevalence of AF in octogenarians has been quoted as 5-15% [26] . Our results seem to suggest that ischemia could be the cause of AF in this patient group; however our numbers were too small to make such conclusions.
Elderly patients are often more passive and have a more accepting manner than younger patients [27] [28] [29] . More recently, this tide is turning with an increase in operative details being requested in all patients, however the greatest increase has been seen in the elderly [30] . If doubt remains about capacity, the patient's ability to retain and effectively communicate the risks and benefits of the intended procedure together the decision regarding the procedure should be assessed [31] . A relatively quick and straightforward test of cognition, the mini-mental state examination, should be carried out [32, 33] .
Review of literature reveals that PCI procedural complication rates were higher in the elderly age group. However this was counter balanced with fewer hospital admissions and improved quality of life [16, 19, [34] [35] [36] . We also observed a positive effect after intervention in our patient group. Out of 19 patients that had PCI, 17 had no hospital admissions for angina over 12 months. The 2 patients that were readmitted had repeat angiography that failed to demonstrate any significant stenosis. Similarly, all 4 patients that had undergone CABG were symptom free for 12 months following surgery. This is in keeping with another retrospective study that has shown that the 30 day and 12 month mortality between octogenarians undergoing PCI or CABG is similar [34] . However, this data is biased as this is non-randomized with only the older patients with the least comorbidities were put forward for intervention. This does however highlight the fact that patient selection is very important in this age group and that a decision to intervene or not should be made on a case by case basis, taking into consideration the co-morbidities and the physical wellbeing, rather than on age alone.
This study is a retrospective audit of the management of elderly patients with a NSTEMI in our institution. It is therefore a purely observational study. In addition, all the information was obtained from the patient case notes and in some instances from the patient's general practitioner. Retrospective analysis of case notes has its limitations as the quality of data is related to the quality of case note documentation, which occasionally may be less than satisfactory. Another drawback of our study was the fact that we did not have many patients with STEMI in our study group. This is because all patients with STEMI are transferred directly to our regional interventional centre and do not come to our hospital.
Conclusions
Octo and nonagenarians represent a significant number of our ACS patients. They also represent a very complex group of patients as there are many other non-medical and medical issues that often make decision making difficult. Guidelines and risk stratification are of limited value in this group as clinical trial data is lacking. Therefore good communication between general medical and cardiology teams are essential in management of older patients. All patients including older patients should be presented with the various treatment options, and their views should be taken into consideration when making the decision whether or not to offer them invasive treatment strategies. Quality of life, and risk benefit assessments are of pivotal importance in our octo and nonagenarians.
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